{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:07Z","timestamp":1792800547900,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"DeGregorio Family Foundation Award","id":[{"id":"https:\/\/ror.org\/051yr1559","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","award":["SAP #4100051723"],"award-info":[{"award-number":["SAP #4100051723"]}],"id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Targeted Diagnostics and Therapeutics, Inc."},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0299"],"award-info":[{"award-number":["W81XWH-17-1-0299"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-PRCRP-TTSA"],"award-info":[{"award-number":["W81XWH-17-PRCRP-TTSA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0067"],"award-info":[{"award-number":["W81XWH-19-1-0067"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0263"],"award-info":[{"award-number":["W81XWH-19-1-0263"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30 CA232469"],"award-info":[{"award-number":["F30 CA232469"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31 CA225123"],"award-info":[{"award-number":["F31 CA225123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA56036"],"award-info":[{"award-number":["P30 CA56036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA204881"],"award-info":[{"award-number":["R01 CA204881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA206026"],"award-info":[{"award-number":["R01 CA206026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM008562"],"award-info":[{"award-number":["T32 GM008562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Courtney Ann Diacont Memorial Foundation"},{"name":"Alfred W. and Mignon Dubbs Fellowship Fund","id":[{"id":"https:\/\/ror.org\/01wddqe20","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adenovirus serotype 5 (Ad5) is a commonly used viral vector for transient delivery of transgenes, primarily for vaccination against pathogen and tumor antigens. However, endemic infections with Ad5 produce virus-specific neutralizing antibodies (NAbs) that limit transgene delivery and constrain target-directed immunity following exposure to Ad5-based vaccines. Indeed, clinical trials have revealed the limitations that virus-specific NAbs impose on the efficacy of Ad5-based vaccines. In that context, the emerging focus on immunological approaches targeting cancer self-antigens or neoepitopes underscores the unmet therapeutic need for more efficacious vaccine vectors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Here, we evaluated the ability of a chimeric adenoviral vector (Ad5.F35) derived from the capsid of Ad5 and fiber of the rare adenovirus serotype 35 (Ad35) to induce immune responses to the tumor-associated antigen guanylyl cyclase C (GUCY2C).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the absence of pre-existing immunity to Ad5, GUCY2C-specific T-cell responses and antitumor efficacy induced by Ad5.F35 were comparable to Ad5 in a mouse model of metastatic colorectal cancer. Furthermore, like Ad5, Ad5.F35 vector expressing GUCY2C was safe and produced no toxicity in tissues with, or without, GUCY2C expression. Importantly, this chimeric vector resisted neutralization in Ad5-immunized mice and by sera collected from patients with colorectal cancer naturally exposed to Ad5.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data suggest that Ad5.F35-based vaccines targeting GUCY2C, or other tumor or pathogen antigens, may produce clinically relevant immune responses in more (\u226590%) patients compared with Ad5-based vaccines (~50%).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2020-001046","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:20:48Z","timestamp":1597972848000},"page":"e001046","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":35,"title":["Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity"],"prefix":"10.1136","volume":"8","author":[{"given":"John C","family":"Flickinger Jr","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagmohan","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Leong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor R","family":"Baybutt","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Barton","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Caparosa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"},{"name":"Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pattison","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Rappaport","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamin","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babar","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"},{"name":"Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Waldman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-4560","authenticated-orcid":false,"given":"Adam E","family":"Snook","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"2025100312470149000_8.2.e001046.1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/d41573-019-00090-z","article-title":"The global pipeline of cell therapies for cancer","volume":"18","author":"Xin Yu","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2025100312470149000_8.2.e001046.2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/d41586-019-00904-5","article-title":"Cellular censuses to guide cancer care","volume":"567","author":"Eisenstein","year":"2019","journal-title":"Nature"},{"key":"2025100312470149000_8.2.e001046.3","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0769-8"},{"key":"2025100312470149000_8.2.e001046.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"2025100312470149000_8.2.e001046.5","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0479-7"},{"key":"2025100312470149000_8.2.e001046.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.011"},{"key":"2025100312470149000_8.2.e001046.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1713444."},{"key":"2025100312470149000_8.2.e001046.8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120775"},{"key":"2025100312470149000_8.2.e001046.9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2025100312470149000_8.2.e001046.10","doi-asserted-by":"publisher","DOI":"10.2174\/1566523213666131125095046"},{"key":"2025100312470149000_8.2.e001046.11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.omtm.2019.11.001","article-title":"Immunology of adenoviral vectors in cancer therapy","volume":"15","author":"Shaw","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2025100312470149000_8.2.e001046.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.025"},{"key":"2025100312470149000_8.2.e001046.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1208972109"},{"key":"2025100312470149000_8.2.e001046.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61592-5"},{"key":"2025100312470149000_8.2.e001046.15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00866-09"},{"key":"2025100312470149000_8.2.e001046.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.12.014"},{"key":"2025100312470149000_8.2.e001046.17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn178"},{"key":"2025100312470149000_8.2.e001046.18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3386"},{"key":"2025100312470149000_8.2.e001046.19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1089\/hgtb.2016.114","article-title":"Preclinical evaluation of a replication-deficient recombinant adenovirus serotype 5 vaccine expressing guanylate cyclase C and the PADRE T-helper epitope","volume":"27","author":"Snook","year":"2016","journal-title":"Hum Gene Ther Methods"},{"key":"2025100312470149000_8.2.e001046.20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444539"},{"key":"2025100312470149000_8.2.e001046.21","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0576-2"},{"key":"2025100312470149000_8.2.e001046.22","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.543"},{"key":"2025100312470149000_8.2.e001046.23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57925"},{"key":"2025100312470149000_8.2.e001046.24","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1227897","article-title":"GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity","volume":"5","author":"Magee","year":"2016","journal-title":"Oncoimmunology"},{"key":"2025100312470149000_8.2.e001046.25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00262-011-1133-0","article-title":"Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C","volume":"61","author":"Snook","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"2025100312470149000_8.2.e001046.26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502672"},{"key":"2025100312470149000_8.2.e001046.27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801206"},{"key":"2025100312470149000_8.2.e001046.28","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0362"},{"key":"2025100312470149000_8.2.e001046.29","unstructured":"R Core Team . R: a language and environment for statistical computing. computer software. Vienna, Austria: R Foundation for Statistical Computing, 2020."},{"key":"2025100312470149000_8.2.e001046.30","doi-asserted-by":"crossref","unstructured":"Venables WN , Ripley BD . Modern applied statistics with S. 4th edn. New York, NY: Springer New York, 2002.","DOI":"10.1007\/978-0-387-21706-2"},{"key":"2025100312470149000_8.2.e001046.31","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.11.2.351-357.2004"},{"key":"2025100312470149000_8.2.e001046.32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2455"},{"key":"2025100312470149000_8.2.e001046.33","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29594"},{"key":"2025100312470149000_8.2.e001046.34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302590"},{"key":"2025100312470149000_8.2.e001046.35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.7179"},{"key":"2025100312470149000_8.2.e001046.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.02.011"},{"key":"2025100312470149000_8.2.e001046.37","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6113.1000461","article-title":"Safety and immunogenicity of a recombinant adenovirus serotype 35-Vectored HIV-1 vaccine in adenovirus serotype 5 seronegative and seropositive individuals","volume":"6","author":"Fuchs","year":"2015","journal-title":"J AIDS Clin Res"},{"key":"2025100312470149000_8.2.e001046.38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4218"},{"key":"2025100312470149000_8.2.e001046.39","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu217"},{"key":"2025100312470149000_8.2.e001046.40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Parker","year":"2013","journal-title":"Gene Ther"},{"key":"2025100312470149000_8.2.e001046.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00243-0"},{"key":"2025100312470149000_8.2.e001046.42","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5304.1320"},{"key":"2025100312470149000_8.2.e001046.43","doi-asserted-by":"publisher","DOI":"10.1038\/nm952"},{"key":"2025100312470149000_8.2.e001046.44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf0685","article-title":"The human vaccines project: a roadmap for cancer vaccine development","volume":"8","author":"Romero","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025100312470149000_8.2.e001046.45","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.140"},{"key":"2025100312470149000_8.2.e001046.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"2025100312470149000_8.2.e001046.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2025100312470149000_8.2.e001046.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"2025100312470149000_8.2.e001046.49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.4238"},{"key":"2025100312470149000_8.2.e001046.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809775"},{"key":"2025100312470149000_8.2.e001046.51","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-001046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:47:13Z","timestamp":1759520833000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,20]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/jitc-2020-001046"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-001046","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}